Carbon dots prepared from ginger exhibiting efficient inhibition of human hepatocellular carcinoma cells

Chi-Lin Li1, Chung-Mao Ou, Chih-Ching Huang

  • 1Department of Chemistry, National Taiwan University, 1, Section 4, Roosevelt Road, Taipei 10617, Taiwan. changht@ntu.edu.tw.

Insights

Fluorescent carbon nanodots from ginger selectively inhibit liver cancer (HepG2) growth with low toxicity. These C-dots upregulate p53, increase reactive oxygen species, and induce apoptosis in cancer cells.

Area of Science:

  • Biomedical Engineering
  • Nanotechnology
  • Cancer Research

Background:

  • Hepatocellular carcinoma (HCC) remains a significant global health challenge.
  • Developing novel, targeted therapies with minimal side effects is crucial.
  • Carbon nanodots (C-dots) are emerging as promising nanomaterials for biomedical applications.

Purpose of the Study:

  • To investigate the anti-cancer properties of fluorescent carbon nanodots derived from ginger extract.
  • To evaluate the selectivity and efficacy of these C-dots against hepatocellular carcinoma cells (HepG2).
  • To elucidate the underlying mechanisms of C-dot-induced cancer cell death.

Main Methods:

  • Synthesis and characterization of fluorescent C-dots from ginger juice.
  • In vitro cytotoxicity assays on HepG2, MCF-10A, FL83B, A549, MDA-MB-231, and HeLa cell lines.
  • Western blot analysis for p53 protein expression.
  • Image cytometry to assess C-dot uptake and reactive oxygen species (ROS) generation.
  • In vivo tumor growth inhibition study in nude mice.

Main Results:

  • C-dots demonstrated high suppression of HepG2 cell growth with low toxicity to normal cells.
  • Selective inhibition of HepG2 cells over other tested cancer cell lines was observed.
  • C-dots upregulated p53 expression specifically in HepG2 cells.
  • Significant ROS production and apoptosis induction were noted in HepG2 cells.
  • In vivo studies showed effective inhibition of tumor growth in nude mice.

Conclusions:

  • Ginger-derived C-dots exhibit potent and selective anti-cancer activity against hepatocellular carcinoma.
  • The mechanism involves p53 upregulation, ROS generation, and apoptosis induction.
  • C-dots represent a potential therapeutic agent for liver cancer with favorable safety profile.